title: Managed care: improving psychiatric drug benefit management: III. The VA's approach to atypical antipsychotics.
authors.affiliation: Harvard Medical School, USA. jim_sabin@hphc.org
authors.forename: James E
authors.initials: JE
authors.lastname: Sabin
authors.forename: Norman
authors.initials: N
authors.lastname: Daniels
mesh_terms: D014150:Antipsychotic Agents / Q000191:economics* / Q000627:therapeutic use; D003363:Cost Control; D019458:Insurance Coverage / Q000592:standards*; D007356:Insurance, Pharmaceutical Services; D008329:Managed Care Programs / Q000592:standards*; D011050:Policy Making; D014481:United States; D014493:United States Department of Veterans Affairs
chemical_list: D014150:Antipsychotic Agents